Comparing NutraHacker's True Detox and PharmaShield (PGx) Panel with Myriad Genetics' GeneSight Psychotropic Panel

September 2, 2024

Back to Curriculum

Introduction

Genetic testing has become a key component in personalized healthcare, offering insights that allow individuals and healthcare providers to tailor medical and lifestyle interventions. This comparison focuses on two significant players: NutraHacker and Myriad Genetics. NutraHacker provides a combined True Detox and PharmaShield (PGx) Panel, while Myriad Genetics offers the GeneSight Psychotropic Panel. This blog post will provide a comprehensive comparison between these two offerings.

1. Overview of the Companies

NutraHacker: Operating since 2013, NutraHacker offers genetic testing services aimed at optimizing health through personalized recommendations. The combined True Detox and PharmaShield (PGx) Panel provides insights into detoxification, pharmacogenomics, and HLA-based adverse drug reactions and allergies.

Myriad Genetics' GeneSight: Myriad Genetics is a leader in genetic testing, focusing on mental health. Their GeneSight Psychotropic Panel is designed to guide the prescription of psychiatric medications based on a patient's genetic profile, aiming to improve medication efficacy and reduce side effects.

2. NutraHacker's True Detox and PharmaShield (PGx) Panel

Purpose: This combined panel is designed to offer a broad spectrum of insights related to detoxification, drug metabolism, and the genetic risk of adverse drug reactions. It includes analysis for detox pathways, pharmacogenomics, and HLA typing.

  • Comprehensive Analysis: Utilizes Whole Genome Sequencing (WGS) to provide a wide-ranging analysis of genetic variants.
  • Detoxification Insights: Focuses on genes involved in detoxification, such as those related to liver enzyme function, antioxidant defenses, and heavy metal processing.
  • Pharmacogenomics: Evaluates a variety of genes impacting drug metabolism, such as those from the CYP450 family, and provides recommendations across numerous drug categories, including cardiovascular, pain management, and psychiatric medications.
  • HLA Analysis: Identifies genetic predispositions to adverse drug reactions and allergies through HLA typing, useful for predicting responses to specific medications.
  • Actionable Recommendations: Offers practical advice on medication adjustments, dietary changes, and supplements to support detoxification and overall health.

3. Myriad Genetics' GeneSight Psychotropic Panel

Purpose: The GeneSight Psychotropic Panel is designed to provide personalized recommendations for psychiatric medications based on a patient’s genetic makeup. This panel helps optimize treatment plans for conditions like depression, anxiety, bipolar disorder, and schizophrenia.

  • Focused Scope: Specifically targets genes relevant to the efficacy and side effects of psychotropic medications.
  • Gene Coverage: Includes key pharmacogenomic genes such as CYP2D6, CYP2C19, CYP1A2, SLC6A4 (serotonin transporter), HTR2A (serotonin receptor), and others relevant to mental health medication response.
  • Clinical Validation: Backed by robust clinical studies demonstrating improved outcomes in psychiatric care when using the GeneSight test to inform medication decisions.
  • Simple and Clear Reporting: Provides a color-coded report that categorizes medications into groups: ‘Use as Directed,’ ‘Moderate Gene-Drug Interaction,’ and ‘Significant Gene-Drug Interaction,’ simplifying the decision-making process for healthcare providers.

4. Comparative Analysis

Scope and Coverage

NutraHacker: Offers a broad approach, encompassing detoxification, pharmacogenomics across various medication categories, and HLA analysis for adverse drug reactions and allergies. This makes it suitable for individuals seeking comprehensive health optimization.

GeneSight: Has a narrow focus on psychiatric medications, making it highly specialized and ideal for mental health professionals seeking to optimize treatment for psychiatric conditions.

Comparing the most similar reports between the two companies, NutraHacker's WGS True Detox and PharmaShield (PGx) Panel analyzes 27 genes, while Genesight examines 15 genes.

The total coverage of variants or star alleles for each gene covered in NutraHacker's WGS True Detox and PharmaShield (PGx) Panel is more than 929 with a full HLA panel computed as well, compared to Genesight's total of only 46 for their Pharmacogenetic report, detailed as follows:

Gene NutraHacker GeneSight
HLA-A Full Diplotype 1 variant
HLA-B Full Diplotype 1 variant
HLA-C Full Diplotype No Coverage
HLA-C Full Diplotype No Coverage
HLA-DPB1 Full Diplotype No Coverage
HLA-DQA1 Full Diplotype No Coverage
HLA-DQB1 Full Diplotype No Coverage
HLA-DRB1 Full Diplotype No Coverage
ABCG2 1 variant No Coverage
CACNA1S 3 variants No Coverage
CFTR 39 variants No Coverage
CYP1A2 No Coverage 1 variant
CYP2B6 46 star alleles 3 star alleles
CYP2C19 34 star alleles 7 star alleles
CYP2C9 85 star alleles 5 star alleles
CYP2D6 179 star alleles 17 star alleles
CYP3A4 45 star alleles 3 star allele
CYP3A5 6 star alleles No Coverage
CYP4F2 15 star alleles No coverage
DPYD 83 variants No coverage
F5 1 variant No coverage
G6PD 224 variants No coverage
IFNL3 1 variant No coverage
NUDT15 20 star alleles No coverage
RYR1 49 variants No coverage
SLCO1B1 42 star alleles No Coverage
TPMT 46 star alleles No coverage
UGT1A1 9 star alleles No coverage
VKORC1 1 variant No coverage
ADRA2A No coverage 1 variant
CES1A1 No coverage 1 variant
COMT No coverage 1 variant
HTR2A No coverage 1 variant
SLC6A4 No coverage 2 variants
UGT1A4 No coverage 1 star allele
UGT2B15 No coverage 1 star allele


Therefore, in total there are 493 star alleles and 402 variants that NutraHacker covers which are not covered by Genesight, and conversely there are only 7 Variants That Genesight covers which NutraHacker currently does not offer coverage for.

In terms of medication and chemical coverage, NutraHacker covers over 2,700 Rxs while Genesight has only approximately 67 covered.

Methodology

NutraHacker: Uses Whole Genome Sequencing, offering extensive genetic insights that go beyond targeted genotyping, including detox pathways and HLA typing.

GeneSight: Employs targeted genotyping to focus specifically on key genes linked to psychotropic medication response, backed by extensive clinical validation.

Actionable Insights

NutraHacker: Provides broad recommendations that cover various health areas, including detoxification, drug metabolism, and susceptibility to adverse reactions.

GeneSight: Offers focused and specific guidance for psychiatric medication management, simplifying the process for mental health providers.

Clinical Application

NutraHacker: Suitable for both healthcare providers and individuals looking for a comprehensive health approach, including detoxification, pharmacogenomics, and risk for adverse drug reactions.

GeneSight: Primarily aimed at mental health professionals to guide the selection and dosing of psychotropic medications, improving patient outcomes in psychiatric care.

5. Conclusion

NutraHacker and Myriad Genetics offer valuable genetic testing services, each tailored to different needs:

  • NutraHacker's True Detox and PharmaShield (PGx) Panel offers a comprehensive solution that includes detoxification insights, pharmacogenomics, and HLA analysis, making it ideal for individuals seeking broad health optimization.
  • GeneSight Psychotropic Panel from Myriad Genetics provides specialized guidance for mental health professionals, focusing on optimizing psychotropic medication use based on genetic makeup.

Deciding between these options depends on the specific health goals and needs of the individual or healthcare provider. NutraHacker's panel is suitable for those seeking a wide-ranging genetic overview, while GeneSight is tailored for psychiatric medication management.

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Receive your NutraHacker free Methylation and Detoxification report here: Upload raw DNA microarray data